Compare HOUR & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOUR | CLNN |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 57.4M |
| IPO Year | 2021 | 2021 |
| Metric | HOUR | CLNN |
|---|---|---|
| Price | $1.97 | $4.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.20 |
| AVG Volume (30 Days) | 17.2K | ★ 128.9K |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 150.00 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $142,440,236.00 | $200,000.00 |
| Revenue This Year | N/A | $24.70 |
| Revenue Next Year | N/A | $9,228.71 |
| P/E Ratio | $40.00 | ★ N/A |
| Revenue Growth | ★ 3.03 | N/A |
| 52 Week Low | $1.67 | $3.25 |
| 52 Week High | $3.18 | $13.50 |
| Indicator | HOUR | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 58.12 | 47.29 |
| Support Level | $1.74 | $3.92 |
| Resistance Level | $2.03 | $4.70 |
| Average True Range (ATR) | 0.10 | 0.38 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 72.73 | 58.62 |
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.